Call us now
08071630660
Urokinase Injection
1 USD ($)/Box
Product Details:
- Appearance White to off-white lyophilized cake or powder
- Assay 100,000 IU per vial (bioactivity determined via chromogenic substrate method)
- Physical Form Injection (Lyophilized Powder for Solution)
- Purity 99%
- Solubility Freely soluble in sterile water for injection
- Pacakaging (Quantity Per Box) 1 vial per box, or as specified by distributor
- Melting Point Not applicable (lyophilized biological product)
- Click to View more
X
Urokinase Injection Price And Quantity
- 1 USD ($)/Box
- 100 Box
Urokinase Injection Product Specifications
- 9039-53-6
- 30043919
- High purity recombinant urokinase, Rapid thrombolysis, Low allergenic potential
- C1376H2145N383O406S18
- Urokinase (human or recombinant), mannitol, sodium chloride, buffer salts
- Store at 2C-8C (Refrigerated), protect from light. Do not freeze.
- 2 Years
- Not applicable (lyophilized biological product)
- 1 vial per box, or as specified by distributor
- As directed by physician. Commonly 250,000 IU to 750,000 IU per administration, intravenous use.
- Adults, Geriatric, sometimes Pediatric (per clinical guidance)
- Freely soluble in sterile water for injection
- Injection (Lyophilized Powder for Solution)
- 99%
- 100,000 IU per vial (bioactivity determined via chromogenic substrate method)
- White to off-white lyophilized cake or powder
- Thrombolytic Agent, Prescription Pharmaceutical
- GMP certified facility
- Intravenous (IV) infusion or local intracatheter instillation.
- Reconstitute with provided sterile water to yield desired IU concentration before administration.
- Bleeding, allergic reactions, hypotension, fever.
- Use with caution in patients with recent stroke, uncontrolled hypertension, or bleeding disorders.
- Sterile, pyrogen-free
- Active internal bleeding, recent surgery, hypersensitivity to urokinase.
- Acute massive pulmonary embolism, acute myocardial infarction, deep vein thrombosis, occluded IV catheters.
- Directly converts plasminogen to plasmin, leading to clot dissolution.
Urokinase Injection Trade Information
- surat
- Cash on Delivery (COD), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Western Union, Paypal, Cash Against Delivery (CAD), Telegraphic Transfer (T/T), Days after Acceptance (DA), Cash in Advance (CID), Cheque, Cash Advance (CA)
- 1000000 Box Per Month
- 4 Days
- Contact us for information regarding our sample policy
- 1 Vial
- Australia, South America, Western Europe, Middle East, Central America, Asia, Eastern Europe, North America, Africa
- Dadra and Nagar Haveli, Himachal Pradesh, Andaman and Nicobar Islands, Nagaland, Uttarakhand, Daman and Diu, Lakshadweep, South India, North India, East India, West India, Assam, Arunachal Pradesh, Bihar, Chandigarh, Goa, Haryana, Jammu and Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Mizoram, Meghalaya, Manipur, Pondicherry, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, West Bengal, Delhi, Gujarat, Punjab, Andhra Pradesh, Kerala, Central India, Odisha, Chhattisgarh, Uttar Pradesh, All India
- ISO/GMP/c-GMP/WHOGMP/USFDA/EUGMP.
Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplier of Urokinase Injection from Surat, Gujarat, India. Urokinase Injection is a serine protease present in humans and other animals.
Tags: Urokinase Injection manufacturer, Urokinase Injection exporter, Urokinase Injection supplier,and Urokinase Injection, whogmp approved Urokinase Injection manufacturer and supplier, Urokinase Injection distributor, Urokinase Injection shipper, Urokinase Injection 10 ml Urokinase Injection 10 ml supplier, Urokinase Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTor CTDossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Mechanism and Clinical Uses
Urokinase acts directly by converting plasminogen to plasmin, which dissolves fibrin clots in blood vessels. It is primarily utilized for life-threatening thrombotic conditions such as acute massive pulmonary embolism, myocardial infarction, deep vein thrombosis, and for unclogging occluded intravenous catheters, promoting swift restoration of blood flow.
Administration and Dosage Guidelines
Urokinase Injection should be administered intravenously or through local intracatheter instillation as per physician's directions. For optimal efficacy, the lyophilized powder must be reconstituted with the provided sterile water to achieve the specified IU concentration. Typical dosing ranges from 250,000 IU up to 750,000 IU per session, tailored to clinical needs and patient population.
Quality, Safety, and Storage
Manufactured under GMP standards, the product is sterile, pyrogen-free, and boasts 99% purity. Caution is critical in patients with recent stroke, uncontrolled hypertension, or bleeding disorders. Proper storage at 2C-8C, protected from light, ensures both efficacy and safety over the 2-year shelf life.
FAQ's of Urokinase Injection:
Q: How does Urokinase Injection function to dissolve blood clots?
A: Urokinase directly converts plasminogen into plasmin, an enzyme that breaks down fibrin within clots, resulting in rapid clot dissolution and the restoration of blood flow.Q: What medical conditions is Urokinase Injection most commonly prescribed for?
A: This injection is primarily used to treat acute massive pulmonary embolism, acute myocardial infarction, deep vein thrombosis, and to clear occluded intravenous catheters.Q: When and how should Urokinase Injection be administered?
A: Urokinase should be administered as an intravenous infusion or as a local instillation into occluded catheters, always following the physician's dosage instructions. Reconstitute the lyophilized powder with the provided sterile water for injectable use.Q: Where should Urokinase Injection be stored for optimal stability?
A: Store vials refrigerated at 2C-8C, protected from light, and avoid freezing to maintain product integrity through its 2-year shelf life.Q: What is the process for preparing Urokinase Injection before use?
A: To prepare, add the supplied sterile water to the vial to reconstitute the lyophilized powder, creating a solution with the prescribed IU concentration for intravenous administration.Q: What benefits does Urokinase Injection provide over other thrombolytic agents?
A: Urokinase offers rapid thrombolysis, a high purity recombinant formulation, and reduced allergenic potential, making it suitable for urgent clinical settings and diverse patient populations.Q: What precautions or contraindications must be observed before using Urokinase Injection?
A: Do not use Urokinase if there is active internal bleeding, recent surgery, or known hypersensitivity. Exercise caution in patients with recent stroke, uncontrolled hypertension, or bleeding disorders.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Cardiac Product' category
SAINTROY LIFESCIENCE LLP
GST : 24AFBFS1718M1ZX
GST : 24AFBFS1718M1ZX
4th Floor, Shop No. 408, Silver Point, Near Devi Darshan Society, Silver Chowk, Puna, Surat, Surat, Gujarat, 395010Surat - 395010, Gujarat, India
Contact Info : Telephone
Mr. Vishal Kathiriya: +91 9662436698
Mr. Keyur Ambaliya: +91 74054 75206
Mail Us:
info@saintroylifescience.com
sales@saintroylifescience.com
Opening Hours:
10:00 AM - 08:00 PM
Contact Info : Telephone
Mr. Vishal Kathiriya: +91 9662436698
Mr. Keyur Ambaliya: +91 74054 75206
Mail Us:
info@saintroylifescience.com
sales@saintroylifescience.com
Opening Hours:
10:00 AM - 08:00 PM
Send InquiryQuick Link
Developed and Managed by Infocom Network Private Limited.
